Title:
CRYSTAL FORM OF PDE-5 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2019/114543
Kind Code:
A1
Abstract:
The present application relates to the field of medicine, and in particular, to a crystal form of a compound as represented by formula (I), a method for preparing the crystal form, a pharmaceutical composition comprising the crystal form, and application of the compounds in preparation of drugs for enhancing cGMP signaling function, particularly the application of the compounds in preparation of drugs for treatment and/or prevention of sexual dysfunction, BPH, LUTS, and the like.
Inventors:
WANG JINYUAN (CN)
WANG ZHENHUA (CN)
WANG ZHENHUA (CN)
Application Number:
PCT/CN2018/117829
Publication Date:
June 20, 2019
Filing Date:
November 28, 2018
Export Citation:
Assignee:
HAINAN XUANZHU PHARMA CO LTD (CN)
International Classes:
C07D403/04; A61K31/506; A61P1/16; A61P9/04; A61P9/12; A61P13/02; A61P13/08; A61P13/10; A61P15/08; A61P15/10
Domestic Patent References:
| WO2014026467A1 | 2014-02-20 |
Foreign References:
| CN105102447B | 2017-08-25 | |||
| CN102372697A | 2012-03-14 | |||
| CN102887889A | 2013-01-23 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
Previous Patent: BLUETOOTH FINANCIAL CARD AND WORKING METHOD THEREFOR
Next Patent: DATA TRANSPORT METHOD, DEVICE AND SYSTEM
Next Patent: DATA TRANSPORT METHOD, DEVICE AND SYSTEM